Rchr
J-GLOBAL ID：201801013960466180
Update date: Nov. 05, 2024
KAIRA Kyouichi
カイラ キョウイチ | KAIRA Kyouichi
Affiliation and department：
Job title：
Professor
Research theme for competitive and other funds (8)：
- 2024 - 2027 肺癌術前化学免疫療法における分子イメージングの効果予測モデルの構築
- 2022 - 2027 Development of immunoprecision medicine for lung cancer using liquid biomarkers
- 2022 - 2026 癌細胞ならびに腫瘍免疫寛容の同時制御を目指した新規治療ツール開発
- 2023 - 2024 膵臓がんにおけるアミノ酸トランスポーター阻害の新規分子標的としての可能性
- 2022 - 2024 PBMCを用いたirAE発症予測システムの開発
- 2021 - 2023 肺神経内分泌腫瘍に対する免疫チェックポイント阻害剤効果予測としてのPETイメージ
- 2021 - 2022 Multicenter Retrospective Study to Evaluate Docetaxel plus Ramucirumab after Combination Therapy with PD-1 Inhibitor and Chemotherapy in Advanced Non-Small Cell Lung Cancer(REACTIVE study)
- 進行肺癌における免疫療法の効果を予測するためのPETと低酸素マーカーの可能性
Show all
Papers (102)：
-
Yamaguchi O, Kasahara N, Soda H, Imai H, Naruse I, Yamaguchi H, Itai M, Taguchi K, Uchida M, Sunaga N, et al. Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib. Sci Rep. 2023. 13. 1
-
Kaira K, Imai H, Mouri A, Hashimoto K, Miura Y, Shiono A, Yamaguchi O, Kobayashi K, Kawasaki T, Yasuda M, et al. Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib. Thorac Cancer. 2023. 14. 29. 2950-2961
-
Asao T, Shukuya T, Mimori T, Goto Y, Tanaka H, Takayama K, Tsubata Y, Tachihara M, Suzuki T, Kaira K, et al. Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101). Clin Lung Cancer. 2023. 24. 7
-
Imai H, Wasamoto S, Tsuda T, Nagai Y, Kishikawa T, Masubuchi K, Osaki T, Miura Y, Umeda Y, Ono A, et al. Using the neutrophil-to-lymphocyte ratio to predict the outcome of individuals with nonsquamous non-small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed. Thoracic Cancer. 2023. 14. 25. 2567-2578
-
Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, et al. Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab. Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab. Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, Kagamu H, Sugasawa M. Sci Rep. 2023. 13. 1. 22557
ｍore...
Lectures and oral presentations (7)：
-
Management and problem of oncologic emergency in advanced lung cancer
(第25回 アジア太平洋呼吸器学会 2021)
-
EGFR遺伝子変異陽性肺がんの EGFR-TKI治療における腫瘍内AXL発現の意義
(第61回 日本呼吸器学会 2021)
-
EGFR遺伝子変異陽性肺がんのEGFR-TKI治療における腫瘍内AXL発現の意義
(第61回 日本呼吸器学会 2021)
-
EGFR-TKI耐性肺癌におけるPD-1阻害剤投与後のEGFR-TKI再投与の効果
(第61回 日本呼吸器学会 2021)
-
Neuroendocrine tumor of the breast with pulmonary metastasis 30 years after mastectomy
(32nd Congress of the European Society of Pathology and XXXIII International Congress of the International Academy of Pathology (Virchows Archiv) 2020)
ｍore...
Awards (4)：
- 2019/11 - EJNMMI Best of Article award
- 2014/06 - 小林がん学術振興会 先駆的研究助成
- 2009/11 - 第47回日本肺癌学会優秀演題賞
- 2007/12 - 群馬大学第一内科同門会賞
Return to Previous Page
